FORSTEO kan medføre mindre stigninger i udskillelsen af calcium i urinen, men forekomsten af hypercalcuri viste sig i de kliniske forsøg ikke at adskille sig fra den, som observeredes hos placebo - behandlede patienter.
FORSTEO may cause small increases in urinary calcium excretion, but the incidence of hypercalciuria did not differ from that in the placebo-treated patients in clinical trials.